NCT00004496View on ClinicalTrials.gov

Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 1999

Study Completion Date

September 30, 2003

Conditions
Acute Renal Failure
Interventions
DRUG

alpha-melanocyte stimulating hormone

Trial Locations (2)

75246

Baylor University Medical Center, Dallas

75235-8897

University of Texas Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
lead

University of Texas

OTHER

NCT00004496 - Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure | Biotech Hunter | Biotech Hunter